SCHEMBL10327396

SCHEMBL10327396

O=C(Nc1ccc(S(=O)(=O)F)cc1)c1ccccc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 2/20 0.75
KMT2A Q03164 6/20 0.71
MEN1 O00255 5/20 0.71
CA12 O43570 1/20 0.71
CA1 P00915 1/20 0.71
CA2 P00918 1/20 0.71
CA9 Q16790 1/20 0.71
HPGD P15428 1/20 0.71
NPC1 O15118 4/20 0.64
RAB9A P51151 4/20 0.64
PTPN1 P18031 2/20 0.62
LMNA P02545 3/20 0.61
KDM4E B2RXH2 2/20 0.61
POLB P06746 2/20 0.61
SIRT1 Q96EB6 1/20 0.61
MAPT P10636 4/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
HTT P42858 1/20 0.60
MAPK1 P28482 1/20 0.59
PSMD14 O00487 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14679074 0.91 CA1 (0.68) PRMT1KMT2AMEN1CA12CA1
SCHEMBL14679075 0.84 PRMT1 (0.77) PRMT1KMT2AMEN1CA12CA1
SCHEMBL126415 0.83 PTPN1 (0.87) PRMT1KMT2AMEN1NPC1RAB9A
SCHEMBL3680148 0.83 PRMT1 (0.75) PRMT1KMT2AMEN1CA12CA1
SCHEMBL3107195 0.83 PRMT1 (0.75) PRMT1KMT2AMEN1CA12CA1
SCHEMBL8422583 0.83 CA2 (1.00) PRMT1KMT2AMEN1CA12CA1
SCHEMBL10327253 0.82 PTGS1 (0.64) PRMT1KMT2AMEN1CA12CA1
SCHEMBL14715824 0.81 NPC1 (0.88) PRMT1KMT2AMEN1HPGDNPC1
SCHEMBL18103163 0.81 NPC1 (0.88) PRMT1KMT2AMEN1HPGDNPC1
SCHEMBL12010897 0.80 KMT2A (0.91) PRMT1KMT2AMEN1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120178747-A9 Compositions and methods for bone formation and remodeling ENZO LIFE SCIENCES, INC. 2012-07-12 US disclosed
US-20100298308-A1 Compositions and methods for bone formation and remodeling ENZO THERAPEUTICS, INC. 2010-11-25 US disclosed
US-4115059-A BLEACHES, DETERGENTS FMC CORPORATION (US) 1978-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298308-A1 Compositions and methods for bone formation and remodeling DKK1, BMP6, LRP6 PRMT1 4518/4885KMT2A 4315/4885MEN1 2078/4885
US-20120178747-A9 Compositions and methods for bone formation and remodeling DKK1, BMP6, LRP6 PRMT1 4518/4885KMT2A 4315/4885MEN1 2078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.